Advertisement

Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention

Published:January 25, 2017DOI:https://doi.org/10.1016/j.amjcard.2016.12.035
      Studies have shown worse outcome for women compared with men after percutaneous coronary intervention (PCI), especially in the presence of diabetes mellitus (DM). We aimed to investigate the risk of ischemic events after PCI in women versus men stratified by the presence or absence of DM. A total of 17,154 consecutive patients from a single-center PCI registry enrolled from January 2009 to December 2014 were categorized accordingly: female/non-DM, female/DM, male/non-DM, and male/DM. End points included death and myocardial infarction (MI) at 1 year. Of the overall population, 15% (n = 2,631) were female/non-DM, 17% (n = 2,891) were female/DM, 38% (n = 6,483) were male/non-DM, and 30% (n = 5,149) were male/DM. Within the 4 study groups, female/DM had the highest risk, whereas female/non-DM and male/DM showed similar risks and male/non-DM showed lowest risk for death (4.64% vs 3.08% vs 2.93% vs 2.31%; p-trend <0.0001 over all groups and p = 0.69 between female/non-DM and male/DM, respectively) and MI (4.15% vs 3.99% vs 3.71% vs 2.55%; p trend <0.0001 over all groups and p = 0.97 between female/non-DM and male/DM, respectively). After multivariate adjustment findings were largely unchanged suggesting highest risk for adverse events in diabetic women compared with other groups and comparable risks for death and MI in nondiabetic women compared with diabetic men. In conclusion, these findings highlight the combined influence of DM and female gender as strong determinants of post-PCI risk while also illustrating “risk equivalence” between nondiabetic women versus diabetic men.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Organisation for Economic Co-operation and Development (2011)
        Health at a Glance 2011: OECD Indicators.
        Organisation for Economic Co-operation and Development, Paris, France2011 (101787/health_glance-2011-en)
        • World Health Organization
        Women and Health: Today’s Evidence Tomorrow’s Agenda.
        WHO, Geneva2009
        • Gu K.
        • Cowie C.C.
        • Harris M.I.
        Diabetes and decline in heart disease mortality in US adults.
        JAMA. 1999; 281: 1291-1297
        • Gregg E.W.
        • Gu Q.
        • Cheng Y.J.
        • Narayan K.M.
        • Cowie C.C.
        Mortality trends in men and women with diabetes, 1971 to 2000.
        Ann Intern Med. 2007; 147: 149-155
        • Kautzky-Willer A.
        • Harreiter J.
        • Pacini G.
        Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus.
        Endocr Rev. 2016; 37: 278-316
        • Roffi M.
        • Radovanovic D.
        • Erne P.
        • Urban P.
        • Windecker S.
        • Eberli F.R.
        • AMIS Plus Investigator
        Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: insights from a nationwide registry 1997-2010.
        Eur Heart J Acute Cardiovasc Care. 2013; 2: 342-349
        • Graham M.M.
        • Ghali W.A.
        • Faris P.D.
        • Galbraith P.D.
        • Norris C.M.
        • Knudtson M.L.
        • APPROACH Investigators
        Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography.
        Diabetes care. 2003; 26: 3142-3147
        • Juutilainen A.
        • Kortelainen S.
        • Lehto S.
        • Ronnemaa T.
        • Pyorala K.
        • Laakso M.
        Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
        Diabetes care. 2004; 27: 2898-2904
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Simoons M.L.
        • Chaitman B.R.
        • White H.D.
        • Katus H.A.
        • Lindahl B.
        • Morrow D.A.
        • Clemmensen P.M.
        • Johanson P.
        • Hod H.
        • Underwood R.
        • Bax J.J.
        • Bonow R.O.
        • Pinto F.
        • Gibbons R.J.
        • Fox K.A.
        • Atar D.
        • Newby L.K.
        • Galvani M.
        • Hamm C.W.
        • Uretsky B.F.
        • Steg P.G.
        • Wijns W.
        • Bassand J.P.
        • Menasche P.
        • Ravkilde J.
        • Ohman E.M.
        • Antman E.M.
        • Wallentin L.C.
        • Armstrong P.W.
        • Simoons M.L.
        • Januzzi J.L.
        • Nieminen M.S.
        • Gheorghiade M.
        • Filippatos G.
        • Luepker R.V.
        • Fortmann S.P.
        • Rosamond W.D.
        • Levy D.
        • Wood D.
        • Smith S.C.
        • Hu D.
        • Lopez-Sendon J.L.
        • Robertson R.M.
        • Weaver D.
        • Tendera M.
        • Bove A.A.
        • Parkhomenko A.N.
        • Vasilieva E.J.
        • Mendis S.
        • Joint ESC/ACCF/AHA/WHF Task Force for the Universial Definition of Mayocardial Infarction
        Third universal definition of myocardial infarction.
        Circulation. 2012; 126: 2020-2035
        • Norhammar A.
        • Schenck-Gustafsson K.
        Type 2 diabetes and cardiovascular disease in women.
        Diabetologia. 2013; 56: 1-9
        • Chandrasekhar J.
        • Baber U.
        • Sartori S.
        • Faggioni M.
        • Aquino M.
        • Kini A.
        • Weintraub W.
        • Rao S.
        • Kapadia S.
        • Weiss S.
        • Strauss C.
        • Toma C.
        • Muhlestein B.
        • DeFranco A.
        • Effron M.
        • Keller S.
        • Baker B.
        • Pocock S.
        • Henry T.
        • Mehran R.
        Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: results from the PROMETHEUS Study.
        Catheter Cardiovasc Interv. 2016; ([Epub ahead of print])https://doi.org/10.1002/ccd.26716
        • Kovacic J.C.
        • Mehran R.
        • Karajgikar R.
        • Baber U.
        • Suleman J.
        • Kim M.C.
        • Krishnan P.
        • Dangas G.
        • Sharma S.K.
        • Kini A.
        Female gender and mortality after percutaneous coronary intervention: results from a large registry.
        Catheter Cardiovasc Interv. 2012; 80: 514-521
        • Kalyani R.R.
        • Lazo M.
        • Ouyang P.
        • Turkbey E.
        • Chevalier K.
        • Brancati F.
        • Becker D.
        • Vaidya D.
        Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults.
        Diabetes care. 2014; 37: 830-838
        • Kannel W.B.
        • McGee D.L.
        Diabetes and cardiovascular disease. The Framingham study.
        JAMA. 1979; 241: 2035-2038
        • Lee W.L.
        • Cheung A.M.
        • Cape D.
        • Zinman B.
        Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies.
        Diabetes care. 2000; 23: 962-968
        • Champney K.P.
        • Veledar E.
        • Klein M.
        • Samady H.
        • Anderson D.
        • Parashar S.
        • Wenger N.
        • Vaccarino V.
        Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time.
        Am Heart J. 2007; 153: 970-978
        • Giralt D.
        • Domingues-Montanari S.
        • Mendioroz M.
        • Ortega L.
        • Maisterra O.
        • Perea-Gainza M.
        • Delgado P.
        • Rosell A.
        • Montaner J.
        The gender gap in stroke: a meta-analysis.
        Acta Neurol Scand. 2012; 125: 83-90
        • Wilson P.W.
        • D'Agostino R.B.
        • Sullivan L.
        • Parise H.
        • Kannel W.B.
        Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.
        Arch Intern Med. 2002; 162: 1867-1872
        • Parodi G.
        • Del Pace S.
        • Carrabba N.
        • Salvadori C.
        • Memisha G.
        • Simonetti I.
        • Antoniucci D.
        • Gensini G.F.
        Incidence, clinical findings, and outcome of women with left ventricular apical ballooning syndrome.
        Am J Cardiol. 2007; 99: 182-185
        • Paffen E.
        • DeMaat M.P.
        C-reactive protein in atherosclerosis: a causal factor?.
        Cardiovasc Res. 2006; 71: 30-39
        • Blomkalns A.L.
        • Chen A.Y.
        • Hochman J.S.
        • Peterson E.D.
        • Trynosky K.
        • Diercks D.B.
        • Brogan Jr., G.X.
        • Boden W.E.
        • Roe M.T.
        • Ohman E.M.
        • Gibler W.B.
        • Newby L.K.
        • CRUSADE Investigators
        Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association guidelines) National Quality Improvement Initiative.
        J Am Coll Cardiol. 2005; 45: 832-837
        • Sharma K.
        • Gulati M.
        Coronary artery disease in women: a 2013 update.
        Glob Heart. 2013; 8: 105-112
        • Regitz-Zagrosek V.
        • Oertelt-Prigione S.
        • Prescott E.
        • Franconi F.
        • Gerdts E.
        • Foryst-Ludwig A.
        • Maas A.H.
        • Kautzky-Willer A.
        • Knappe-Wegner D.
        • Kintscher U.
        • Ladwig K.H.
        • Schenck-Gustafsson K.
        • Stangl V.
        • Group EUCCS
        Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
        Eur Heart J. 2016; 37: 24-34
        • Bonaa K.H.
        • Mannsverk J.
        • Wiseth R.
        • Aaberge L.
        • Myreng Y.
        • Nygard O.
        • Nilsen D.W.
        • Klow N.E.
        • Uchto M.
        • Trovik T.
        • Bendz B.
        • Stavnes S.
        • Bjornerheim R.
        • Larsen A.I.
        • Slette M.
        • Steigen T.
        • Jakobsen O.J.
        • Bleie O.
        • Fossum E.
        • Hanssen T.A.
        • Dahl-Eriksen O.
        • Njolstad I.
        • Rasmussen K.
        • Wilsgaard T.
        • Nordrehaug J.E.
        • Investigators N.
        Drug-eluting or bare-metal stents for coronary artery disease.
        N Engl J Med. 2016; 375: 1242-1252
        • Group A.C.
        • Patel A.
        • MacMahon S.
        • Chalmers J.
        • Neal B.
        • Billot L.
        • Woodward M.
        • Marre M.
        • Cooper M.
        • Glasziou P.
        • Grobbee D.
        • Hamet P.
        • Harrap S.
        • Heller S.
        • Liu L.
        • Mancia G.
        • Mogensen C.E.
        • Pan C.
        • Poulter N.
        • Rodgers A.
        • Williams B.
        • Bompoint S.
        • de Galan B.E.
        • Joshi R.
        • Travert F.
        Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
        N Engl J Med. 2008; 358: 2560-2572
        • Natarajan S.
        • Liao Y.
        • Sinha D.
        • Cao G.
        • McGee D.L.
        • Lipsitz S.R.
        Sex differences in the effect of diabetes duration on coronary heart disease mortality.
        Arch Intern Med. 2005; 165: 430-435
        • Register T.C.
        • Divers J.
        • Bowden D.W.
        • Carr J.J.
        • Lenchik L.
        • Wagenknecht L.E.
        • Hightower R.C.
        • Xu J.
        • Smith S.C.
        • Hruska K.A.
        • Langefeld C.D.
        • Freedman B.I.
        Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study.
        J Clin Endocrinol Metab. 2013; 98: 1916-1922
        • Wade A.N.
        • Fedyna S.
        • Mehta N.N.
        • St Clair C.
        • Ginwala N.
        • Krishna R.K.
        • Qasim A.N.
        • Braunstein S.
        • Iqbal N.
        • Schutta M.H.
        • Reilly M.P.
        Type 2 diabetes does not attenuate racial differences in coronary calcification.
        Diabetes Res Clin Pract. 2011; 91: 101-107